Vaccine for operational forces will come from the Defense Supply Center Philadelphia (DSCP), and will be distributed following the seasonal influenza vaccine model. Operational forces will only receive the Novartis injectable vaccine.

For OCONUS dependents and retirees, vaccine will be supplied according to the seasonal influenza vaccine distribution model. Sanofi Pasteur Injectable multi-dose vials will be distributed to military treatment facilities overseas.

For CONUS beneficiaries (including Alaska and Hawaii) military treatment facility (MTF) commanders, in coordination with installation public health emergency officers (PHEOs), will register through their respective states as an immunizer to vaccinate dependents and retirees. The state, in turn, will submit this request to the CDC. The CDC will supply vaccine to the state. The state will coordinate with the vaccine distributor and the installation to have the vaccine delivered to the MTF. Beneficiaries will receive the CSL Biotherapies, Sanofi Pasteur, or MedImmune vaccine.

Within the civilian community, there will be multiple sites offering vaccine. DoD civilians and contractors are encouraged to seek vaccine through non-DoD sources when available as this will likely result in quicker access to vaccine. (http://www.cdc.gov/h1n1flu/vaccination/statecontacts.htm).

H1N1 vaccinations should begin immediately upon receipt of H1N1 influenza vaccine to protect individuals at risk from developing influenza or its complications. All Services will follow Service–specific implementation guidelines.